ATE223204T1 - Liposomenzusammensetzung - Google Patents

Liposomenzusammensetzung

Info

Publication number
ATE223204T1
ATE223204T1 AT93908075T AT93908075T ATE223204T1 AT E223204 T1 ATE223204 T1 AT E223204T1 AT 93908075 T AT93908075 T AT 93908075T AT 93908075 T AT93908075 T AT 93908075T AT E223204 T1 ATE223204 T1 AT E223204T1
Authority
AT
Austria
Prior art keywords
liposome composition
peyer
glands
phosphatidylinositol
cholesterol
Prior art date
Application number
AT93908075T
Other languages
English (en)
Inventor
Syuji Sato
Iwao Nozawa
Katsuhiko Akiyama
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE223204T1 publication Critical patent/ATE223204T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93908075T 1992-04-10 1993-04-09 Liposomenzusammensetzung ATE223204T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11802592 1992-04-10
PCT/JP1993/000460 WO1993020801A1 (fr) 1992-04-10 1993-04-09 Composition de liposomes

Publications (1)

Publication Number Publication Date
ATE223204T1 true ATE223204T1 (de) 2002-09-15

Family

ID=14726206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93908075T ATE223204T1 (de) 1992-04-10 1993-04-09 Liposomenzusammensetzung

Country Status (8)

Country Link
US (1) US5573779A (de)
EP (1) EP0728476B1 (de)
KR (1) KR100217826B1 (de)
AT (1) ATE223204T1 (de)
AU (1) AU668934B2 (de)
CA (1) CA2117769C (de)
DE (1) DE69332276T2 (de)
WO (1) WO1993020801A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9400600A (pt) * 1994-02-17 1995-10-24 Finep Financiadora De Estudos Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos
IL121070A (en) 1995-10-12 2004-06-20 Supergen Inc LIPOSOME FORMULATIONS OF 5beta STEROIDS
AU682805B1 (en) * 1996-03-22 1997-10-16 Biosphere Technologies Inc. Method for inducing a systemic immune response to an antigen
US6117449A (en) * 1996-03-22 2000-09-12 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to a hepatitis antigen
US6207185B1 (en) * 1996-03-22 2001-03-27 Bio-Sphere Technology Method for inducing a systemic immune response to an HIV antigen
US6015576A (en) * 1997-08-29 2000-01-18 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to an antigen
US20020136762A1 (en) * 1998-01-14 2002-09-26 See Jackie R. Method for inducing a systemic immune response to an antigen
WO1999065467A1 (en) * 1998-06-16 1999-12-23 See Jackie R Method for introducing a chemical agent into the systemic circulation
WO2002009678A2 (en) * 2000-07-31 2002-02-07 Ottawa Heart Institute Research Corporation Charged phospholipid compositions and methods for their use
FR2836043B1 (fr) * 2002-02-15 2004-06-04 Inst Nat Sante Rech Med Vesicules lipidiques, preparation et utilisations
JP5160534B2 (ja) * 2006-03-30 2013-03-13 ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク 低免疫原性および長時間循環性タンパク質−脂質複合体の組成物
US7875288B2 (en) * 2006-03-30 2011-01-25 The Research Foundation Of State University Of New York Method for treating blood coagulation disorders
US20090081284A1 (en) * 2006-04-20 2009-03-26 Tokai University Educational System Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
US20080138351A1 (en) * 2006-08-02 2008-06-12 United Therapeutics Corporation Liposome treatment of viral infections
US20090252785A1 (en) * 2008-03-26 2009-10-08 University Of Oxford Endoplasmic reticulum targeting liposomes
CN102427804A (zh) * 2009-03-27 2012-04-25 牛津大学之校长及学者 降低胆固醇水平的脂质体
US10617640B2 (en) 2009-07-07 2020-04-14 The Research Foundation For The State University Of New York Phosphoserine containing compositions for immune tolerance induction
EP2763659B1 (de) * 2011-10-06 2017-07-19 The Research Foundation Of State University Of New York Zusammensetzungen und verfahren zur induzierung von immuntoleranz
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
AU2014239883B2 (en) 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
FR3119325B1 (fr) * 2021-01-29 2023-08-11 Renault Jean Yves Compositions liposomales orales

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645444A1 (de) * 1976-10-08 1978-04-13 Karl Dr Med Theurer Verfahren zur gewinnung von oral wirksamen arzneimitteln und impfstoffen aus primaer nicht darmwirksamen praeparaten
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4952405A (en) * 1988-10-20 1990-08-28 Liposome Technology, Inc. Method of treating M. avium infection
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
JPH03236325A (ja) * 1989-12-11 1991-10-22 Sumitomo Chem Co Ltd ウイルス感染細胞を殺傷するリポソーム
EP0432693A1 (de) * 1989-12-11 1991-06-19 Sumitomo Chemical Company, Limited Für virusinfizierte Zellen cytotoxische Liposomen
FI944052A7 (fi) * 1992-03-03 1994-09-02 Daiichi Seiyaku Co Oraalinen rokote

Also Published As

Publication number Publication date
AU668934B2 (en) 1996-05-23
US5573779A (en) 1996-11-12
CA2117769A1 (en) 1993-10-11
EP0728476A4 (de) 1997-09-10
CA2117769C (en) 2003-07-22
KR100217826B1 (ko) 1999-09-01
EP0728476A1 (de) 1996-08-28
KR950700725A (ko) 1995-02-20
DE69332276D1 (de) 2002-10-10
DE69332276T2 (de) 2003-01-09
EP0728476B1 (de) 2002-09-04
AU3904193A (en) 1993-11-18
WO1993020801A1 (fr) 1993-10-28

Similar Documents

Publication Publication Date Title
KR950700725A (ko) 리포솜 조성물(liposome composition)
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
ES2130420T3 (es) Preparado transdermico de sustancia activa.
DE58905028D1 (de) Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel.
ES8801118A1 (es) Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado.
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
ATE65392T1 (de) In mizellulare phospholipidische partikel eingekapselte antineoplastische anthracyclinmittel.
NO304982B1 (no) Fosfolipid, fosfatidyletanolamin, farmas°ytisk, nµrings eller kosmetisk blanding omfattende nevnte fosfolipid eller fosfatidyletanolamin
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
DK0871476T3 (da) Tørret blodfaktorpræparat indeholdende trehalose
DK0699068T3 (da) Reduktion af liposominducerede fysiologiske bivirkninger
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
ES2077904T3 (es) Obtencion y uso de preparados estables de liposomas en forma de pequeñas particulas.
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
ES2124328T3 (es) Liposomas que contienen diacetato de clorhexidina o digluconato de clorhexidina.
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
AU586988B2 (en) Solid drug formulations and stable suspensions
ZA91115B (en) Topical compositions
FR2619505B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
SG168394G (en) Method and formulation for orally administering bioactive agents to and through the peyer's patch

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties